Research ArticleBrain
MR Imaging Features of Amyloid-Related Imaging Abnormalities
J. Barakos, R. Sperling, S. Salloway, C. Jack, A. Gass, J.B. Fiebach, D. Tampieri, D. Melançon, Y. Miaux, G. Rippon, R. Black, Y. Lu, H.R. Brashear, H.M. Arrighi, K.A. Morris and M. Grundman
American Journal of Neuroradiology October 2013, 34 (10) 1958-1965; DOI: https://doi.org/10.3174/ajnr.A3500
J. Barakos
aFrom the California Pacific Medical Center (J.B.), San Francisco, California
bSynarc (J.B., Y.M.), Newark, California
R. Sperling
cBrigham and Women's Hospital (R.S.), Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
S. Salloway
dWarren Alpert Medical School of Brown University (S.S.), Providence, Rhode Island
C. Jack
eMayo Clinic (C.J.), Rochester, Minnesota
A. Gass
fUniversity Hospital Mannheim (A.G.), University of Heidelberg, Mannheim, Germany
J.B. Fiebach
gCenter for Stroke Research (J.B.F.), Charité, Berlin, Germany
D. Tampieri
hNeuroRx Research (D.T., D.M.), Montreal, Quebec, Canada
D. Melançon
hNeuroRx Research (D.T., D.M.), Montreal, Quebec, Canada
Y. Miaux
bSynarc (J.B., Y.M.), Newark, California
G. Rippon
iPfizer Inc (G.R., R.B.), Collegeville, Pennsylvania
R. Black
iPfizer Inc (G.R., R.B.), Collegeville, Pennsylvania
Y. Lu
aFrom the California Pacific Medical Center (J.B.), San Francisco, California
H.R. Brashear
jJanssen Alzheimer Immunotherapy Research & Development, LLC (H.R.B., H.M.A., K.A.M., M.G.), South San Francisco, California
H.M. Arrighi
jJanssen Alzheimer Immunotherapy Research & Development, LLC (H.R.B., H.M.A., K.A.M., M.G.), South San Francisco, California
K.A. Morris
jJanssen Alzheimer Immunotherapy Research & Development, LLC (H.R.B., H.M.A., K.A.M., M.G.), South San Francisco, California
M. Grundman
jJanssen Alzheimer Immunotherapy Research & Development, LLC (H.R.B., H.M.A., K.A.M., M.G.), South San Francisco, California
kGlobal Partners Inc (M.G.), Cambridge, Massachusetts.

Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
American Journal of Neuroradiology
Vol. 34, Issue 10
1 Oct 2013
Advertisement
J. Barakos, R. Sperling, S. Salloway, C. Jack, A. Gass, J.B. Fiebach, D. Tampieri, D. Melançon, Y. Miaux, G. Rippon, R. Black, Y. Lu, H.R. Brashear, H.M. Arrighi, K.A. Morris, M. Grundman
MR Imaging Features of Amyloid-Related Imaging Abnormalities
American Journal of Neuroradiology Oct 2013, 34 (10) 1958-1965; DOI: 10.3174/ajnr.A3500
MR Imaging Features of Amyloid-Related Imaging Abnormalities
J. Barakos, R. Sperling, S. Salloway, C. Jack, A. Gass, J.B. Fiebach, D. Tampieri, D. Melançon, Y. Miaux, G. Rippon, R. Black, Y. Lu, H.R. Brashear, H.M. Arrighi, K.A. Morris, M. Grundman
American Journal of Neuroradiology Oct 2013, 34 (10) 1958-1965; DOI: 10.3174/ajnr.A3500
Jump to section
Related Articles
- No related articles found.
Cited By...
- Alzheimer Disease Anti-Amyloid Immunotherapies: Imaging Recommendations and Practice Considerations for Monitoring of Amyloid-Related Imaging Abnormalities
- Monoclonal Antibodies: What the Diagnostic Neuroradiologist Needs to Know
- Incidence of Amyloid-Related Imaging Abnormalities in Patients With Alzheimer Disease Treated With Anti-{beta}-Amyloid Immunotherapy: A Meta-analysis
- Amyloid-Related Imaging Abnormalities with Emerging Alzheimer Disease Therapeutics: Detection and Reporting Recommendations for Clinical Practice
- Aducanumab Use in Symptomatic Alzheimer Disease Evidence in Focus: A Report of the AAN Guidelines Subcommittee
- Tumefactive Primary Central Nervous System Vasculitis: Imaging Findings of a Rare and Underrecognized Neuroinflammatory Disease
- Leptomeningeal contrast enhancement and blood-CSF barrier dysfunction in aseptic meningitis
This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.
More in this TOC Section
Similar Articles
Advertisement